EXAS

EXAS Company Financials

$10.58
*  
0.18
  negative  
1.67%
Get EXAS Alerts
*Delayed - data as of May 22, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010 12/31/2009
Total Revenue
$4,144 $4,163 $5,344 $4,758
Cost of Revenue
$0 $24 $24 $20
Gross Profit
$4,144 $4,139 $5,320 $4,738
Operating Expenses
Research and Development
$42,131 $21,968 $9,023 $4,213
Sales, General and Admin.
$14,655 $10,994 $8,123 $9,775
Non-Recurring Items
$0 $0 $0 ($3)
Other Operating Items
$0 $0 $0 $0
Operating Income
($52,642) ($28,823) ($11,826) ($9,247)
Add'l income/expense items
$262 $169 $290 $120
Earnings Before Interest and Tax
($52,380) ($28,654) ($11,536) ($9,127)
Interest Expense
$41 $21 $20 $1
Earnings Before Tax
($52,421) ($28,675) ($11,556) ($9,128)
Income Tax
$0 $0 $0 $0
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($52,421) ($28,675) ($11,556) ($9,128)
Net Income
($52,421) ($28,675) ($11,556) ($9,128)
Net Income Applicable to Common Shareholders
($52,421) ($28,675) ($11,556) ($9,128)

See also: Company Financials data entry page